Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Università degli Studi dell'Insubria
From the Italian VATS Group Database, we selected patients who underwent video-assisted thoracoscopic lobectomy for non-small cell lung cancer. We calculated the aggregate risk score and the corresponding class of 90-day mortality risk for each patient. The correlation between risk classes and mortality rates was tested by Spearman's rho-test. Model calibration was evaluated by Hosmer-Lemeshow goodness-of-fit test.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\- Patients undergoing VATS lobectomy for non-small cell lung cancer
You may not be if
Incomplete data for risk score calculation
Tumor size \>5 cm
Follow-up \<3 months
Patients undergoing neoadjuvant treatment
Patients undergoing extended resection
Clareo Health | Assessment of the 90-day Mortality Risk Score After VATS Lobectomy
